Latest filing published 25 Jul 2024 for InnoCan Pharma Corporation, €17k.
No signal scores available.
This profile gathers the share dealings of Nelson Harvey Halpern in InnoCan Pharma Corporation. The record holds 7 filings, for trades running from 13 September 2019 to 25 July 2024.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 25 July 2024, reports a transaction of €17k in InnoCan Pharma Corporation. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations